Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
52.49 BRL | +2.99% | +1.59% | +4.15% |
Jun. 11 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Jun. 11 | Sector Update: Health Care | MT |
Sales 2024 * | 88.79B 480B | Sales 2025 * | 92.1B 498B | Capitalization | 353B 1,910B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.98 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.83 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 131,900 |
Yield 2024 * |
3.29% | Yield 2025 * |
3.43% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +2.99% | ||
1 week | +1.59% | ||
Current month | +2.12% | ||
1 month | +1.49% | ||
3 months | -2.81% | ||
6 months | +2.62% | ||
Current year | +4.15% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 52.49 | +2.99% | 396 |
24-06-11 | 52.44 | -0.23% | 3,036 |
24-06-10 | 52.56 | +0.50% | 2,896 |
24-06-07 | 52.3 | +1.63% | 2,874 |
24-06-06 | 51.46 | -0.41% | 4,645 |
Delayed Quote Sao Paulo, June 12, 2024 at 10:04 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+48.15% | 780B | |
+41.63% | 627B | |
+20.17% | 334B | |
+6.74% | 296B | |
+17.04% | 244B | |
-0.82% | 217B | |
+11.54% | 214B | |
+4.50% | 161B | |
-3.90% | 159B |
- Stock Market
- Equities
- JNJ Stock
- JNJB34 Stock